title: Comparative effects of neurotensin, neurotensin(8-13) and [D-Tyr(11)]neurotensin applied into the ventral tegmental area on extracellular dopamine in the rat prefrontal cortex and nucleus accumbens.
abstract: Ejections of 10(-5)-10(-3)M neurotensin into the ventral tegmental area increased dopamine efflux measured by electrochemical approaches in the prefrontal cortex of anaesthetized rats. In the same conditions, the effects evoked on dopamine efflux by 10(-5)M neurotensin(8-13) and [D-Tyr(11)]neurotensin were different from each other and depended on the explored area: the prefrontal cortex and the caudal and rostral nucleus accumbens. In the prefrontal cortex, neurotensin(8-13) was as potent as neurotensin, whereas [D-Tyr(11)]neurotensin was ineffective. In the caudal nucleus accumbens, when considering the initial intensity of the effect, neurotensin(8-13) and neurotensin appeared more potent than [D-Tyr(11)]neurotensin. In contrast, in the rostral nucleus accumbens, neurotensin(8-13) was less potent than [D-Tyr(11)]neurotensin and neurotensin. These results support the differential involvement of two pharmacologically distinct neurotensin receptor entities on ventral tegmental area neurons in the modulation of mesolimbic and mesocortical dopaminergic activity.
authors.affiliation: Laboratoire de Neuropharmacologie et Neurochimie, INSERM U 512, Faculté de Pharmacie, Université Claude Bemard-Lyon I, 8 avenue Rockefeller, 69373 Cedex 08, Lyon, France.
authors.forename: F
authors.initials: F
authors.lastname: Sotty
authors.forename: P
authors.initials: P
authors.lastname: Brun
authors.forename: M
authors.initials: M
authors.lastname: Leonetti
authors.forename: R
authors.initials: R
authors.lastname: Steinberg
authors.forename: P
authors.initials: P
authors.lastname: Soubrié
authors.forename: B
authors.initials: B
authors.lastname: Renaud
authors.forename: M F
authors.initials: MF
authors.lastname: Suaud-Chagny
mesh_terms: D000818:Animals; D004298:Dopamine / Q000378:metabolism*; D004563:Electrochemistry; D005110:Extracellular Space / Q000378:metabolism; D008297:Male; D008845:Microinjections; D009496:Neurotensin / Q000031:analogs & derivatives / Q000494:pharmacology*; D009714:Nucleus Accumbens / Q000378:metabolism*; D010446:Peptide Fragments / Q000494:pharmacology*; D017397:Prefrontal Cortex / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017557:Ventral Tegmental Area / Q000187:drug effects*
chemical_list: D010446:Peptide Fragments; D009496:Neurotensin; C054381:neurotensin (8-13); C068445:neurotensin, Tyr(11)-; D004298:Dopamine